Jump Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Jump Financial’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	+3,900	New	+$313K	﹤0.01%	1654
2026 Q1	–	Sell	-16,500	Closed	-$1.3M	–	1861
2025 Q4	$1.3M	Sell	16,500 -53,229	-76%	-$4.61M	0.02%	871
2025 Q3	$6.39M	Buy	69,729 +22,309	+47%	+$1.82M	0.08%	335
2025 Q2	$3.09M	Buy	47,420 +24,199	+104%	+$1.58M	0.03%	581
2025 Q1	$1.55M	Buy	+23,221	New	+$1.39M	0.02%	670
2024 Q4	–	Sell	-24,270	Closed	-$1.45M	–	1618
2024 Q3	$1.45M	Buy	24,270 +17,578	+263%	+$1.07M	0.03%	644
2024 Q2	$426K	Sell	6,692 -1,747	-21%	-$113K	0.01%	1200
2024 Q1	$583K	Buy	+8,439	New	+$509K	0.02%	1091
2023 Q4	–	Sell	-21,500	Closed	-$1.25M	–	1754
2023 Q3	$1.25M	Buy	21,500 +2,699	+14%	+$156K	0.05%	568
2023 Q2	$1.01M	Buy	18,801 +5,301	+39%	+$235K	0.04%	672
2023 Q1	$536K	Buy	+13,500	New	+$569K	0.02%	863
2021 Q3	–	Sell	-6,700	Closed	-$235K	–	1082
2021 Q2	$235K	Buy	+6,700	New	+$228K	0.02%	779

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's ANIP Position: Q2 2026 in Review

Jump Financial opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 3,900 shares worth $323K. The stake represents ﹤0.01% of the portfolio and ranks #1654 among its holdings. This is a return to the name: Jump Financial previously reported a position in ANIP as recently as Q4 2025.

Jump Financial first reported a position in ANIP in Q2 2021 and has held it in 12 quarters since. The position peaked at $6.39M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Jump Financial held 3,900 shares of ANI Pharmaceuticals worth $323K as of Q2 2026.
ANI Pharmaceuticals was a new Jump Financial position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1654 holding.
Jump Financial first reported a position in ANI Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
Jump Financial's ANI Pharmaceuticals position peaked at $6.39M in Q3 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.